Immunotherapy for lymphoma / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 633-637, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-659116
ABSTRACT
At present,immunotherapies for lymphoma are becoming gradually important.Chimeric antigen receptor-modified T cells therapy,bispecific antibody and immune-checkpoint inhibitor are considered as breakthrough treatments,each has its own unique mechanism,and more advanced treatments will be developed based on them.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS